Stocks · News reference

Barclays Maintains Overweight on First Tracks, Raises Price Target to $65

Aug 13, 2026, 2:09 PMBenzinga Newsdesk

Barclays analyst Etzer Darout maintains First Tracks (NASDAQ:TRAX) with a Overweight and raises the price target from $48 to $65.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 13, 2026, 1:07 PMAvi Kapoor
First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results
TRAX reported narrower Q2 loss of 95 cents per share. Analysts raised price targets for the stock, citing potential for ANB033 in immune diseases.
Read original at benzinga
TRAX
BenzingaAug 13, 2026, 1:00 PMBenzinga Newsdesk
Wedbush Maintains Outperform on First Tracks, Raises Price Target to $70
Wedbush analyst Martin Fan maintains First Tracks (NASDAQ:TRAX) with a Outperform and raises the price target from $60 to $70.
Read original at benzinga
TRAX
BenzingaAug 13, 2026, 12:06 PMBenzinga Newsdesk
Piper Sandler Maintains Overweight on First Tracks, Raises Price Target to $95
Piper Sandler analyst Yasmeen Rahimi maintains First Tracks (NASDAQ:TRAX) with a Overweight and raises the price target from $54 to $95.
Read original at benzinga
TRAX